Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations

Cancer patients have an incidence of about 60% kidney disease development and are at elevated risk of acute renal damage. Kidney disease in these patients is frequently associated with nephrotoxicity from the ongoing oncological treatment. New anticancer therapeutic strategies, such as targeted ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Piscitani, Luca, Sirolli, Vittorio, Di Liberato, Lorenzo, Morroni, Manrico, Bonomini, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402330/
https://www.ncbi.nlm.nih.gov/pubmed/32664269
http://dx.doi.org/10.3390/ijms21144878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402330/
https://www.ncbi.nlm.nih.gov/pubmed/32664269
http://dx.doi.org/10.3390/ijms21144878

Ejemplares similares